AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report) shares crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $2.79 and traded as high as $6.25. AIkido Pharma shares last traded at $5.55, with a volume of 233,412 shares changing hands.
AIkido Pharma Stock Performance
The business’s fifty day simple moving average is $4.85 and its 200-day simple moving average is $2.81. The firm has a market capitalization of $25.83 million, a PE ratio of -1.21 and a beta of 0.93.
AIkido Pharma Company Profile
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Featured Articles
- Five stocks we like better than AIkido Pharma
- Election Stocks: How Elections Affect the Stock Market
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Conference Calls and Individual Investors
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Why Are Stock Sectors Important to Successful Investing?
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
